Similarly, lower expression of TAT, HGD and GSTZ1 could also translate to a worse disease-free survival in HCC patients (p  =  0.011, p  =  0.0038 and p  =  0.036, respectively) (S2 Fig). The gene discussed is GSTZ1; the disease is hepatocellular carcinoma.